Literature DB >> 20679612

Multigene assays to improve assessment of recurrence risk and benefit from chemotherapy in early-stage colon cancer: has the time finally arrived, or are we still stage locked?

Josep Tabernero, José Baselga.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20679612     DOI： 10.1200/JCO.2010.30.0806

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.

Authors:  Wenyuan Zhao; Beibei Chen; Xin Guo; Ruiping Wang; Zhiqiang Chang; Yu Dong; Kai Song; Wen Wang; Lishuang Qi; Yunyan Gu; Chenguang Wang; Da Yang; Zheng Guo
Journal:  Oncotarget       Date:  2016-04-05

2.  The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67.

Authors:  Il Yong Shin; Na Young Sung; Youn Soo Lee; Taek Soo Kwon; Yoon Si; Yoon Suk Lee; Seong Taek Oh; In Kyu Lee
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.